Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-22-042110
Filing Date
2022-02-14
Accepted
2022-02-14 17:03:00
Documents
3
Group Members
KEVIN P. STARRMARK LEVINROBERT I. TEPPERTHIRD ROCK VENTURES GP III, L.P.TRV GP III, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G d275847dsc13g.htm SC 13G 125095
2 EX-99.1 d275847dex991.htm EX-99.1 7889
3 EXHIBIT 24 d275847dex9924.htm EX-99.24 4327
  Complete submission text file 0001193125-22-042110.txt   138970
Mailing Address 29 NEWBURY STREET, 3RD FLOOR BOSTON MA 02116
Business Address 29 NEWBURY STREET, 3RD FLOOR BOSTON MA 02116 617-585-2000
Third Rock Ventures III, L.P. (Filed by) CIK: 0001569705 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215 617-370-8701
Decibel Therapeutics, Inc. (Subject) CIK: 0001656536 (see all company filings)

EIN.: 464198709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92302 | Film No.: 22634312
SIC: 2834 Pharmaceutical Preparations